OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 3

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 48.7% 959,749 1,970,227 48.5% 0.2%
Sex Female 48.8% 512,568 1,049,650 48.7% 0.2%
Male 48.6% 447,181 920,577 48.4% 0.2%
Ethnicity White - British 49.7% 600,362 1,208,536 49.5% 0.1%
White - Irish 43.1% 7,196 16,702 42.8% 0.3%
White - Any other White background 39.5% 17,052 43,169 39.3% 0.2%
Mixed - White and Black Caribbean 39.6% 854 2,156 39.3% 0.3%
Mixed - White and Black African 37.7% 427 1,134 37.7% 0.0%
Mixed - White and Asian 40.1% 525 1,309 40.1% 0.0%
Mixed - Any other mixed background 39.8% 903 2,268 39.2% 0.6%
Asian or Asian British - Indian 39.6% 10,115 25,550 39.3% 0.2%
Asian or Asian British - Pakistani 40.6% 4,298 10,591 39.5% 1.1%
Asian or Asian British - Bangladeshi 42.7% 1,246 2,919 41.7% 1.0%
Asian or Asian British - Any other Asian background 37.0% 4,235 11,431 36.8% 0.2%
Black or Black British - Caribbean 36.0% 4,116 11,431 35.2% 0.9%
Black or Black British - African 31.6% 2,541 8,050 30.7% 0.9%
Black or Black British - Any other Black background 34.7% 609 1,757 34.3% 0.4%
Other ethnic groups - Chinese 36.6% 1,162 3,178 36.1% 0.4%
Other ethnic groups - Any other ethnic group 40.0% 2,555 6,384 39.4% 0.7%
Patients with any other ethnicity code 49.2% 136,241 276,745 49.1% 0.2%
Ethnicity not stated 48.2% 5,656 11,725 48.1% 0.2%
Ethnicity not recorded 49.1% 159,544 325,080 48.9% 0.2%
Ethnicity (broad categories) White 49.2% 624,624 1,268,428 49.1% 0.1%
Mixed 39.6% 2,730 6,888 39.2% 0.4%
South Asian 39.4% 19,915 50,505 38.9% 0.5%
Black 34.3% 7,287 21,252 33.4% 0.9%
Other 38.9% 3,724 9,562 38.4% 0.5%
Unknown 49.1% 301,448 613,564 49.0% 0.2%
Index of Multiple Deprivation 1 (most deprived) 47.7% 123,872 259,721 47.3% 0.3%
2 47.1% 156,618 332,647 46.9% 0.2%
3 48.8% 204,694 419,461 48.6% 0.2%
4 49.0% 225,204 459,676 48.9% 0.1%
5 (least deprived) 49.9% 241,353 483,399 49.8% 0.1%
Unknown 52.2% 7,987 15,288 52.0% 0.3%
Clinical Risk Groups Patients in Any Clinical Risk Group 49.4% 573,223 1,159,865 49.2% 0.2%
Patients with Immunosuppression 49.2% 42,168 85,722 49.0% 0.2%
Patients with CKD 49.6% 160,104 322,896 49.4% 0.2%
Patients who have Chronic Respiratory Disease 50.3% 112,826 224,133 50.1% 0.2%
Patients with Diabetes 49.1% 180,432 367,192 48.9% 0.2%
Patients with Chronic Liver disease 48.6% 25,375 52,164 48.5% 0.2%
Patients with CNS Disease (including Stroke/TIA) 51.7% 110,103 212,800 51.5% 0.2%
Patients with Chronic heart disease 49.8% 294,147 591,045 49.6% 0.2%
Patients with Asplenia or Dysfunction of the Spleen 49.4% 8,477 17,143 49.3% 0.2%
Patients with Wider Learning Disability 58.6% 1,365 2,331 57.4% 1.2%
Patients with Severe Mental Health 51.6% 8,141 15,792 51.0% 0.5%
Other Groups Patients who are shielding (High Risk from COVID-19) 49.8% 153,286 307,671 49.6% 0.3%
Patients with Morbid Obesity 51.7% 24,710 47,768 51.5% 0.3%
Patients who are pregnant 53.1% 119 224 53.1% 0.0%